|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.77 CNY | +0.22% |
|
+5.25% | +33.27% |
| 07-09 | Gan & Lee Pharmaceuticals sees H1 net profit up 100.7-114.1% Y/Y | RE |
| 07-08 | Gan & Lee Pharmaceuticals' Insulin Aspart Receives Approval in Argentina | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 58.9 | 58.9 | 65.9 |
| Spread/Res. | -0.22% | -0.22% | -10.82% |
| Spread/Supp. | +9.93% | +17.31% | +23.23% |
| Support | 53.46 | 50.1 | 47.69 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 603087 Stock
- Charts Gan & Lee Pharmaceuticals.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition